Article info
PDFCardiovascular genetics
Review
New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides
- Correspondence to Professor Dongye Li, Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China; dongyeli{at}xzhmu.edu.cn
Citation
New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides
Publication history
- Received October 17, 2017
- Revised January 30, 2018
- Accepted February 5, 2018
- First published February 24, 2018.
Online issue publication
June 15, 2020
Article Versions
- Previous version (27 April 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.